Citadel Advisors
HCM icon

Citadel Advisors’s HUTCHMED HCM Stock Holding History

Citadel Advisors’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,900
Closed -$149K – 13533
2025
Q1 		$149K Buy
9,900
+1,700
+21% +$25.1K ﹤0.01% 10884
2024
Q4 		$118K Buy
8,200
+2,000
+32% +$35.7K ﹤0.01% 11217
2024
Q3 		$121K Buy
6,200
+2,400
+63% +$43.4K ﹤0.01% 10863
2024
Q2 		$65.1K Buy
3,800
+1,100
+41% +$20.3K ﹤0.01% 11463
2024
Q1 		$45.4K Buy
2,700
+400
+17% +$6.07K ﹤0.01% 12253
2023
Q4 		$41.7K Sell
2,300
-2,600
-53% -$47.3K ﹤0.01% 11978
2023
Q3 		$83K Buy
4,900
+1,500
+44% +$21.5K ﹤0.01% 11124
2023
Q2 		$40.8K Sell
3,400
-2,400
-41% -$32.7K ﹤0.01% 12044
2023
Q1 		$75.5K Buy
5,800
+5,100
+729% +$83.6K ﹤0.01% 11642
2022
Q4 		$10.3K Buy
+700
New +$7.65K ﹤0.01% 13625
2021
Q3 		– Sell
-22,600
Closed -$888K – 14133
2021
Q2 		$888K Buy
+22,600
New +$653K ﹤0.01% 8659

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's HCM Position: Q1 2026 in Review

Citadel Advisors increased its HUTCHMED (HCM) stake by 18% in Q1 2026, buying an estimated $69.4K and bringing the position to 30,514 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #9520.

Citadel Advisors first reported a position in HCM in Q1 2018 and has held it in 26 quarters since. The position peaked at $3.21M in Q4 2022. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Citadel Advisors held 30,514 shares of HUTCHMED worth $456K as of Q1 2026.
  • Citadel Advisors bought 4,747 HUTCHMED shares in Q1 2026, an estimated $69.4K.
  • HUTCHMED made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9520 holding.
  • Citadel Advisors first reported a position in HUTCHMED in Q1 2018 and has held it in 26 quarters since.
  • Citadel Advisors's HUTCHMED position peaked at $3.21M in Q4 2022.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.